Market Overview:
The global hypertrophic and keloid scar therapy market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of skin injuries, increasing awareness about available treatment options, and technological advancements in scar therapy products. The global hypertrophic and keloid scar therapy market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into topical products, laser products, injectable products, and others. The topical product segment dominates the global hypertrophic and keloid scar therapy market owing to its easy availability and low cost as compared to other types of therapies. On the basis of application, hospitals account for a major share of the global hypertrophic and keloid scar therapy market followed by clinics due to increasing number of surgeries performed in these settings worldwide.
Product Definition:
Hypertrophic and Keloid Scar Therapy is the use of treatments to improve or prevent the development of hypertrophic and keloid scars. Treatment may include laser therapy, surgery, compression therapy, or silicone gel sheets. The importance of Hypertrophic and Keloid Scar Therapy is that it can help improve the appearance of scars and reduce their size.
Topical Products:
Topical products are the drugs, creams and ointments that are applied to the skin for treating a particular disorder or disease. Topical products can be used in two ways; topically, i.e. by applying them directly to the affected area or systemically, i.e. by administering them into the body through vein or oral route so that they can act on target organs as well as tissues throughout the body (in case of pain relief).
Laser Products:
A laser is a tool that produces light for the treatment of various skin conditions. The most common application of lasers is in cosmetic procedures such as skin tightening, acne reduction, and removal of body marks like tattoos. However, these devices are also used in medical applications such as photodynamic therapy (PDT), which uses a combination of laser and photo-sensitive drugs to treat cancer cells.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and other medical facilities, and others. The others segment includes plastic surgery centers and dermatology offices. Hospitals were the largest revenue generating centers in 2017 due to high usage rates of scar treatment devices in hospital based settings. Furthermore, rising cases of trauma related injuries across the globe is further expected to drive demand for these products over the forecast period.
The clinics & other medical facilities segment held a significant share of revenue in 2017 owing to increasing awareness about cosmetic surgeries among people aged 30+ years coupled with growing preference for non-invasive procedures due to advancement in technology related to lasers & lights sources used for treating scars at outpatient level which was not available few years ago resulting in increased adoption rate among patients seeking aesthetic treatments from private institutes or surgeons at their residences or places of work which eventually resulted in higher utilization rates compared to hospitals thus contributing towards overall market growth during that year.
Regional Analysis:
Europe dominated the global market in 2017 owing to the growing number of cosmetic surgeries and rising incidence of burns. In addition, a large number of companies present in this region are involved in R&D activities for developing new products. The presence of major players such as Medytox, LLC; Lumenis Ltd.; Symmetry Surgical Inc.; and Derma Sciences Inc. is also contributing towards growth in Europe.
Asia Pacific is expected to witness lucrative growth over the forecast period due to increasing awareness about hypertrophic and keloid scars among patients, coupled with rising medical tourism especially for laser treatment procedures performed at affordable costs compared to western countries. Increasing penetration of international manufacturers such as LASER & Tissue Center; Beauty Without Bounds; Laser & Cosmetic Centre Pte Ltd., Singapore into emerging Asian markets has been helping these treatments gain wider acceptance across this region over the past few years.
Growth Factors:
- Increasing incidence of skin injuries and disorders
- Growing awareness about the benefits of hypertrophic and keloid scar therapy
- Rising demand for minimally invasive procedures
- Technological advancements in hypertrophic and keloid scar therapy devices and therapies
- Growing number of clinical studies on hypertrophic and keloid scar therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Hypertrophic and Keloid Scar Therapy Market Research Report
By Type
Topical Products, Laser Products, Injectable, Others,
By Application
Hospitals, Clinics, Others,
By Companies
Smith & Nephew, Enaltus, Merz, Lumenis, Sonoma Pharmaceuticals, Cynosure, Scar Heal, Mölnlycke Health, Perrigo, NewMedical Technology, Suneva Medical, Pacific World
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Hypertrophic and Keloid Scar Therapy Market Report Segments:
The global Hypertrophic and Keloid Scar Therapy market is segmented on the basis of:
Types
Topical Products, Laser Products, Injectable, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smith & Nephew
- Enaltus
- Merz
- Lumenis
- Sonoma Pharmaceuticals
- Cynosure
- Scar Heal
- Mölnlycke Health
- Perrigo
- NewMedical Technology
- Suneva Medical
- Pacific World
Highlights of The Hypertrophic and Keloid Scar Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical Products
- Laser Products
- Injectable
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hypertrophic and Keloid Scar Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hypertrophic and keloid scar therapy is a type of medical treatment that uses heat, massage, and other therapies to help heal scars. Hypertrophic scars are raised or thickened scars that may be caused by an increase in the production of collagen. Keloid scarring is a type of scarring that occurs when too much elastin (a protein found in skin) is produced. Both types of scar can be difficult to treat and may require multiple treatments over time.
Some of the major companies in the hypertrophic and keloid scar therapy market are Smith & Nephew, Enaltus, Merz, Lumenis, Sonoma Pharmaceuticals, Cynosure, Scar Heal, MƒÂ¶lnlycke Health, Perrigo, NewMedical Technology, Suneva Medical, Pacific World.
The hypertrophic and keloid scar therapy market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hypertrophic and Keloid Scar Therapy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hypertrophic and Keloid Scar Therapy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hypertrophic and Keloid Scar Therapy Market - Supply Chain
4.5. Global Hypertrophic and Keloid Scar Therapy Market Forecast
4.5.1. Hypertrophic and Keloid Scar Therapy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hypertrophic and Keloid Scar Therapy Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hypertrophic and Keloid Scar Therapy Market Absolute $ Opportunity
5. Global Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Type
5.3.1. Topical Products
5.3.2. Laser Products
5.3.3. Injectable
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hypertrophic and Keloid Scar Therapy Demand Share Forecast, 2019-2026
9. North America Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Type
9.7.1. Topical Products
9.7.2. Laser Products
9.7.3. Injectable
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hypertrophic and Keloid Scar Therapy Demand Share Forecast, 2019-2026
10. Latin America Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Type
10.7.1. Topical Products
10.7.2. Laser Products
10.7.3. Injectable
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hypertrophic and Keloid Scar Therapy Demand Share Forecast, 2019-2026
11. Europe Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Type
11.7.1. Topical Products
11.7.2. Laser Products
11.7.3. Injectable
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hypertrophic and Keloid Scar Therapy Demand Share, 2019-2026
12. Asia Pacific Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Type
12.7.1. Topical Products
12.7.2. Laser Products
12.7.3. Injectable
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hypertrophic and Keloid Scar Therapy Demand Share, 2019-2026
13. Middle East & Africa Hypertrophic and Keloid Scar Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hypertrophic and Keloid Scar Therapy Market Size and Volume Forecast by Type
13.7.1. Topical Products
13.7.2. Laser Products
13.7.3. Injectable
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hypertrophic and Keloid Scar Therapy Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hypertrophic and Keloid Scar Therapy Market: Market Share Analysis
14.2. Hypertrophic and Keloid Scar Therapy Distributors and Customers
14.3. Hypertrophic and Keloid Scar Therapy Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Smith & Nephew
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Enaltus
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merz
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Lumenis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sonoma Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cynosure
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Scar Heal
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Mölnlycke Health
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Perrigo
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. NewMedical Technology
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Suneva Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Pacific World
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
